triazoles has been researched along with nsc 23766 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Al-Jabi, N; Ali, A; Bajbouj, K; Hamad, M; Jabal, RA; Muhammad, JS; Shafarin, J; Unnikannan, H | 1 |
1 other study(ies) available for triazoles and nsc 23766
Article | Year |
---|---|
Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.
Topics: Aminoquinolines; Animals; Azepines; Breast Neoplasms; Carcinogenesis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Female; Ferritins; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Histone Deacetylase 1; Histone-Lysine N-Methyltransferase; Humans; Mice; Mice, Nude; Oxidoreductases; Proto-Oncogene Proteins c-myc; Pyrimidines; rac1 GTP-Binding Protein; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2021 |